Gilead follows Kite acquisition with $567m buy

12-12-2017

Gilead Sciences has built on its acquisition of cell therapy company Kite Pharma with another purchase.


Gilead Sciences, Kite, cellular therapy, genetics, technology platforms, mergers & acquisitions, CAR T therapy

LSIPR